First Command Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.1K Buy
195
+128
+191% +$24.5K ﹤0.01% 484
2026
Q1
$12.3K Buy
+67
New +$12.3K ﹤0.01% 567
2024
Q3
Sell
-12
Closed -$2.78K 473
2024
Q2
$2.78K Buy
+12
New +$2.61K ﹤0.01% 424
2020
Q4
Sell
-24
Closed -$7K 37
2020
Q3
$7K Buy
+24
New +$6.69K ﹤0.01% 23

Other funds holding BIIB

First Command Advisory Services's BIIB Position: Q2 2026 in Review

First Command Advisory Services increased its Biogen (BIIB) stake by 191% in Q2 2026, buying an estimated $24.5K and bringing the position to 195 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

First Command Advisory Services first reported a position in BIIB in Q3 2020 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • First Command Advisory Services held 195 shares of Biogen worth $42.1K as of Q2 2026.
  • First Command Advisory Services bought 128 Biogen shares in Q2 2026, an estimated $24.5K.
  • Biogen made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #484 holding.
  • First Command Advisory Services first reported a position in Biogen in Q3 2020 and has held it in 4 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.